Guyana vs South-Eastern Asia: Proportion of the target population who received
Guyana
97.0%
in 2024
South-Eastern Asia
81.0%
in 2024
Guyana rank
21st
South-Eastern Asia rank
16th
Proportion of the target population who received over time
- Guyana
- South-Eastern Asia
How they compare
Guyana currently reports 97.0% against 81.0% in South-Eastern Asia, a difference of 16.0%.
That makes Guyana's figure about 1.2 times South-Eastern Asia's.
Across all 24 years both countries report, Guyana has been ahead every year.
Guyana ranks 21st and South-Eastern Asia ranks 16th of 193 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.4% | 30.1% | 48.3% | Guyana |
| 2010s | 90.0% | 67.7% | 22.3% | Guyana |
| 2020s | 95.0% | 71.8% | 23.2% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Guyana or South-Eastern Asia?
- Guyana, at 97.0% against 81.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received between Guyana and South-Eastern Asia?
- 16.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and South-Eastern Asia?
- 24 years are reported by both, from 2001 to 2024.
- How do Guyana and South-Eastern Asia rank globally for proportion of the target population who received?
- Guyana ranks 21st and South-Eastern Asia ranks 16th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.